Us TOO is proud to offer our 2021 webinar series, What is Right for Me in My Prostate Cancer Treatment? The fifth, and final, webinar in this series is a discussion on the topic of Genetics and Genomics. Genetics and genomics technology is changing rapidly and there are a growing number of options available to help guide treatment decisions. Join us as we discuss the latest developments in this exciting area.

Genetics and Genomics 

Dr. Brittany Szymaniak is a genetic counselor in the Urology Department at Northwestern Medicine and has expertise in GU and GI related hereditary cancer syndromes. She is passionate about increasing provider and patient awareness of prostate cancer genetics and the role of genetic counselors. She is a member of the NCCN High Risk Assessment Colorectal Panel, which focuses on hereditary colorectal cancer and polyposis syndromes. Dr. Szymaniak has been highly involved in the development of Northwestern’s Early Detection in Genetics (EDGe) Program, which aims to provide coordinated and comprehensive care to individuals with hereditary cancer syndromes. As part of this program, Dr. Szymaniak is the lead genetic counselor for the EDGe BRCA+ Men’s Clinic, as well as the EDGe VHL (von-Hippel Lindau) Clinic. Dr. Szymaniak also provides counseling for male infertility and is working with a retinal specialist to develop a genetics program within the Ophthalmology department. In addition to her appointment in Urology, Dr. Szymaniak has a faculty appointment with Northwestern University's Graduate Program in Genetic Counseling, serving as a lecturer and thesis advisor. 

Genetic Counselor, Urology Department

Northwestern Medicine

Professor - Medical Oncology, Cancer Biology, and Urology

Director, Cancer Risk Assessment and Clinical Cancer Genetics

Sidney Kimmel Cancer Center

Thomas Jefferson University